{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:53:34Z","timestamp":1792151614769,"version":"4.4.0"},"reference-count":15,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Program of the Brazilian National Health System"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"abstract":"<jats:p>ABSTRACT  Background: This study aimed to synthesize evidence on the safety of tuberculosis-preventive treatment (TPT) in children aged &lt;5 years, including those with immunocompromising conditions.  Methods:  A rapid review was conducted using PubMed, Embase, Virtual Health Library, and the Cochrane Library, including systematic reviews and primary studies.  Results:  Five studies were included, assessing isoniazid-based regimens. Adverse events were mild and reversible, such as transient liver enzyme elevations and peripheral neuropathy. Severe hepatotoxicity was rare and primarily reported in children with Human Immunodeficiency Virus (HIV).  Conclusions:  TPT appears generally safe in children aged &lt;5 years; however, evidence remains limited for shorter regimens and immunocompromised populations.<\/jats:p>","DOI":"10.1590\/0037-8682-0029-2026","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:18:19Z","timestamp":1792149499000},"source":"Crossref","is-referenced-by-count":0,"title":["Safety of tuberculosis-preventive treatment in children aged under 5 years: A rapid review"],"prefix":"10.1590","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4935-2432","authenticated-orcid":false,"given":"Liza Yurie Teruya","family":"Uchimura","sequence":"first","affiliation":[{"name":"Hcor","place":["S\u00e3o Paulo, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8271-6691","authenticated-orcid":false,"given":"Tatiana","family":"Yonekura","sequence":"additional","affiliation":[{"name":"Hcor","place":["S\u00e3o Paulo, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0076-9242","authenticated-orcid":false,"given":"Jeane Roza","family":"Quintans","sequence":"additional","affiliation":[{"name":"Hcor","place":["S\u00e3o Paulo, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4195-3732","authenticated-orcid":false,"given":"Mabel Fernandes","family":"Figueir\u00f3","sequence":"additional","affiliation":[{"name":"Hcor","place":["S\u00e3o Paulo, SP, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8608-4864","authenticated-orcid":false,"given":"Karina dos Santos","family":"Casado","sequence":"additional","affiliation":[{"name":"Minist\u00e9rio da Sa\u00fade","place":["Bras\u00edlia, DF, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2688-2999","authenticated-orcid":false,"given":"Eduardo de Souza","family":"Alves","sequence":"additional","affiliation":[{"name":"Minist\u00e9rio da Sa\u00fade","place":["Bras\u00edlia, DF, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1762-9484","authenticated-orcid":false,"given":"Fernanda Dockhorn Costa","family":"Johansen","sequence":"additional","affiliation":[{"name":"Minist\u00e9rio da Sa\u00fade","place":["Bras\u00edlia, DF, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-1875","authenticated-orcid":false,"given":"Daniele Maria","family":"Pelissari","sequence":"additional","affiliation":[{"name":"Minist\u00e9rio da Sa\u00fade","place":["Bras\u00edlia, DF, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9372-7385","authenticated-orcid":false,"given":"Nicole Menezes de","family":"Souza","sequence":"additional","affiliation":[{"name":"Minist\u00e9rio da Sa\u00fade","place":["Bras\u00edlia, DF, Brasil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","series-title":"Epidemiological Bulletin - Tuberculosis 2025 [Internet].","year":"2025"},{"key":"ref2","series-title":"Global tuberculosis report 2024","year":"2024"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jclinepi.2020.10.007","article-title":"Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews","volume":"130","author":"Garritty C","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","journal-title":"BMJ"},{"key":"ref5","series-title":"JBI critical appraisal tools","year":"2025"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"ofad087","DOI":"10.1093\/ofid\/ofad087","article-title":"Tuberculosis diagnosis and preventive monotherapy among children and adolescents exposed to rifampicin-resistant tuberculosis in the household","volume":"10","author":"Apolisi I","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa827","article-title":"A randomized controlled trial of isoniazid to prevent Mycobacterium tuberculosis infection in Kenyan human immunodeficiency virus-exposed uninfected infants","volume":"73","author":"Lacourse SM","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"8","key":"ref8","first-page":"CD006418","article-title":"Isoniazid for preventing tuberculosis in HIV-infected children","volume":"8","author":"Zunza M","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5588\/ijtld.12.0641","article-title":"Twice-weekly therapy for children with tuberculosis infection or exposure","volume":"17","author":"Cruz AT","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5588\/ijtld.11.0820","article-title":"Safety of long-term isoniazid preventive therapy in children with HIV: a comparison of two dosing schedules","volume":"17","author":"Le Roux SM","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref11","first-page":"ciaf404","article-title":"Safety, feasibility and rifapentine plasma concentration in Chinese children with 1 month of daily rifapentine plus isoniazid for tuberculosis infection","author":"Liu W","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12879-025-10832-7","article-title":"Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: a systematic review","volume":"25","author":"Pangprasertkul S","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jped.2023.02.002","article-title":"Tuberculosis preventive treatment in children and adolescents: an observational study of secondary data","volume":"99","author":"Tahan TT","year":"2023","journal-title":"J Pediatr"},{"key":"ref14","first-page":"ciag073","article-title":"Shorter Antitubercular Regimens Versus 9 Months of Isoniazid for Latent Tuberculosis in Children: A Systematic Review and Meta-Analysis","author":"Kosenko M","year":"2026","journal-title":"Clin Infect Dis"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/INF.0000000000004767","article-title":"Completion, safety and tolerability of once-weekly isoniazid and rifapentine for tuberculosis infection by children and adolescents","volume":"44","author":"Cruz AT","year":"2025","journal-title":"Pediatr Infect Dis J"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0037-86822026000101413&tlng=en","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0037-86822026000101413&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:18:21Z","timestamp":1792149501000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822026000101413&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"alternative-id":["S0037-86822026000101413"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0029-2026","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"value":"1678-9849","type":"electronic"},{"value":"0037-8682","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e0029-2026"}}